This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Teagasc, the Agriculture and Food Development Authority, The Provost, Fellows, Foundation Scholars & the Other Members of Board, of He College of the Holy & Undiv. Trinity of Queen El, The Provost, Fellows, Foundation Scholars, & the Other Members of Board, of the College of the Holy. Active years: 2022-2026.
Company Filing History:
1 out of 10 
1 out of 1 
1 out of 3 
Years Active: 2022-2026
Title: Innovations by Inventor Sarah Doyle in Retinal Treatments
Introduction
Sarah Doyle, an innovative inventor based in Dublin, Ireland, has made significant contributions to the field of eye health through her patents. With a total of three patents to her name, Doyle focuses on groundbreaking treatments for age-related macular degeneration (AMD) and other degenerative retinal conditions.
Latest Patents
Her latest patent addresses the treatment of age-related macular degeneration, particularly emphasizing geographic atrophy (GA) and advanced dry AMD. The invention pertains to the use of inner-blood-retinal-barrier (iBRB) or blood-brain-barrier (BBB) tight junction proteins and circadian clock proteins for both the prevention and treatment of AMD.
Additionally, Doyle's composition and methods for the treatment of degenerative retinal conditions target inflammatory mediators, specifically components or substrates of the NLRP3-inflammasome. This invention not only proposes methods for treating conditions involving drusen and anaphylatoxin-induced choroidal-neovascularization but also includes developing recombinant proteins and vectors for effective treatments. Furthermore, she presents a method for determining the risk of developing or monitoring the progression of diseases related to drusen and choroidal neo-vascularisation.
Career Highlights
Throughout her career, Sarah has associated with prestigious institutions, including the College of the Holy and Undivided Trinity of Queen Elizabeth. This environment has fostered her innovative spirit and allowed her to contribute meaningfully to her field.
Collaborations
Sarah Doyle has collaborated with esteemed colleagues such as Matthew Campbell and Natalie Hudson. These partnerships have been critical in advancing her research and developing her patented treatments.
Conclusion
With her innovative approaches and determination, Sarah Doyle continues to impact the field of retinal health profoundly. Her inventions serve not only as a testament to her creativity as an inventor but also as a beacon of hope for those affected by degenerative retinal conditions.